Funding: This project was supported by the National Natural Science Foundation of China (No. 82073566), the University Young and Middle-aged Teacher Training Project from the Educational Commission of Anhui Province (DTR2023012), the Health Research Project of Anhui Province (AHWJ2023A20294), the Anhui Public Health Clinical Center, the First Affiliated Hospital of Anhui Medical University North Area Scientific Research Cultivation Fund Project (2023YKJ11, 2023YKJ06 and 2023YKJ14) and the Anhui Medical University Scientific Research Fund project (2023xkj043).

Read the full text

About

PDF

Tools

Share a link

Email
Wechat
Bluesky

ABSTRACT

As a commonly used phthalate compound, di(2-ethylhexyl) phthalate (DEHP) has been shown to disrupt the tricarboxylic acid (TCA) cycle and aggravate tissue damage. However, whether the TCA cycle is involved in cholestatic liver injury (CLI) induced by DEHP and the protective effect of dimethyl fumarate (DMF), which is used to supplement TCA intermediate metabolites, remained unclear. Here, mice were randomized into five groups (n = 6/group): (1) Control, (2) DEHP (200 mg/kg/day), (3) DMF (100 mg/kg/day), (4) DEHP + DMF (30 mg/kg/day) and (5) DEHP + DMF (100 mg/kg/day). Our data demonstrated that DEHP exposure upregulated total bile acid (TBA) levels and broke the TCA cycle, resulting in reduced fumaric acid and malic acid. However, we further supplemented fumaric acid with DMF and found that DMF effectively reversed the high levels of TBA, alkaline phosphatase (ALP) and glutamyl transpeptidase (GGT) induced by DEHP in mice. Meanwhile, pathological results in the liver showed that DMF improved bile duct cell damage, inflammatory cell infiltration, collagen deposition and necrosis caused by DEHP. In addition, we found that DEHP elevated the level of interleukin (IL)-1β, IL-6, TNF-α and MDA and decreased the level of SOD in the mouse liver, which was effectively reversed by DMF treatment. Besides, DMF upregulated the expression of Nrf2 and NQO1 in the liver of DEHP-exposed mice. For in vitro validation, AML-12 cells were treated with (1) Control, (2) DEHP (250 μM), (3) DEHP + DMF (10 μM), (4) DEHP + DMF (25 μM) and (5) DEHP + DMF (50 μM). DEHP exposure increased the expression of IL-1β, IL-6 and TNF-α, which was mitigated by DMF, while ML385, an Nrf2 inhibitor, could counteract the anti-inflammatory effects of DMF. These findings indicate that DEHP broke the TCA cycle of the mouse liver, and DMF supplementation protects against DEHP-induced CLI by activating the Nrf2/NQO1 pathway.

Conflicts of Interest

The authors declare no conflicts of interest.

Open Research

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

References

1Y. Zhao, H. X. Li, Y. Luo, J. G. Cui, M. Talukder, and J. L. Li, “Lycopene Mitigates DEHP-Induced Hepatic Mitochondrial Quality Control Disorder via Regulating SIRT1/PINK1/Mitophagy Axis and Mitochondrial Unfolded Protein Response,” Environmental Pollution 292 no. Pt B (2022): 118390.
10.1016/j.envpol.2021.118390
Google Scholar
2Y. Q. Huang, Y. X. Tang, B. H. Qiu, M. Talukder, X. N. Li, and J. L. Li, “Di-2-Ethylhexyl Phthalate (DEHP) Induced Lipid Metabolism Disorder in Liver via Activating the LXR/SREBP-1c/PPARalpha/Gamma and NF-kappaB Signaling Pathway,” Food and Chemical Toxicology 165 (2022): 113119.
10.1016/j.fct.2022.113119
CAS PubMed Google Scholar
3D. Lo, Y. T. Wang, and M. C. Wu, “Hepatoprotective Effect of Silymarin on Di(2-ethylhexyl)phthalate (DEHP) Induced Injury in Liver FL83B Cells,” Environmental Toxicology and Pharmacology 38, no. 1 (2014): 112–118.
10.1016/j.etap.2014.05.005
CAS PubMed Web of Science® Google Scholar
4Y. Zhang, H. Qian, J. Wang, et al., “Di-(2-ethylhexyl) Phthalate (DEHP) Promoted Hepatic Lipid Accumulation by Activating Notch Signaling Pathway,” Environmental Toxicology 38, no. 7 (2023): 1628–1640.
10.1002/tox.23792
CAS PubMed Web of Science® Google Scholar
5J. C. Caldwell, “DEHP: Genotoxicity and Potential Carcinogenic Mechanisms—A Review,” Mutation Research 751, no. 2 (2012): 82–157.
10.1016/j.mrrev.2012.03.001
CAS PubMed Web of Science® Google Scholar
6Z. Yu, Z. Shi, Z. Zheng, et al., “DEHP Induce Cholesterol Imbalance via Disturbing Bile Acid Metabolism by Altering the Composition of Gut Microbiota in Rats,” Chemosphere 263 (2021): 127959.
10.1016/j.chemosphere.2020.127959
CAS PubMed Web of Science® Google Scholar
7Q. Shi, X. Yuan, Y. Zeng, et al., “Crosstalk Between Gut Microbiota and Bile Acids in Cholestatic Liver Disease,” Nutrients 15, no. 10 (2023): 15102411.
10.3390/nu15102411
Web of Science® Google Scholar
8S. Y. Cai and J. L. Boyer, “The Role of Bile Acids in Cholestatic Liver Injury,” Annals of Translational Medicine 9, no. 8 (2021): 737.
10.21037/atm-20-5110
CAS PubMed Web of Science® Google Scholar
9M. Li, S. Y. Cai, and J. L. Boyer, “Mechanisms of Bile Acid Mediated Inflammation in the Liver,” Molecular Aspects of Medicine 56 (2017): 45–53.
10.1016/j.mam.2017.06.001
CAS PubMed Web of Science® Google Scholar
10A. A. M. El-Faramawy, L. B. E. El-Shazly, A. A. Abbass, et al., “Serum IL-6 and IL-8 in Infants With Biliary Atresia in Comparison to Intrahepatic Cholestasis,” Tropical Gastroenterology 32, no. 1 (2011): 50–55.
10.4103/TROG_20103201_50
PubMed Google Scholar
11M. Sasaki, M. Miyakoshi, Y. Sato, et al., “Chemokine-Chemokine Receptor CCL2-CCR2 and CX3CL1-CX3CR1 Axis May Play a Role in the Aggravated Inflammation in Primary Biliary Cirrhosis,” Digestive Diseases and Sciences 59, no. 2 (2014): 358–364.
10.1007/s10620-013-2920-6
CAS PubMed Web of Science® Google Scholar
12Z. Weng, Y. Chi, J. Xie, et al., “Anti-Inflammatory Activity of Dehydroandrographolide by TLR4/NF-kappaB Signaling Pathway Inhibition in Bile Duct-Ligated Mice,” Cellular Physiology and Biochemistry 49, no. 3 (2018): 1083–1096.
10.1159/000493292
PubMed Web of Science® Google Scholar
13X. Luan, P. Chen, Y. Li, et al., “TNF-Alpha/IL-1beta-Licensed hADSCs Alleviate Cholestatic Liver Injury and Fibrosis in Mice via COX-2/PGE2 Pathway,” Stem Cell Research & Therapy 14, no. 1 (2023): 100.
10.1186/s13287-023-03342-3
CAS PubMed Web of Science® Google Scholar
14R. Heidari and H. Niknahad, “The Role and Study of Mitochondrial Impairment and Oxidative Stress in Cholestasis,” Methods in Molecular Biology 2019 (1981): 117–132.
Google Scholar
15Q. Gao, G. Li, Y. Zu, et al., “Ginsenoside Rg1 Alleviates ANIT-Induced Cholestatic Liver Injury by Inhibiting Hepatic Inflammation and Oxidative Stress via SIRT1 Activation,” Journal of Ethnopharmacology 319, no. Pt 1 (2024): 117089.
10.1016/j.jep.2023.117089
CAS PubMed Google Scholar
16E. J. Lee, Y. P. Hong, and Y. J. Yang, “Short-Term Exposure to Di(2-ethylhexyl)phthalate May Disrupt Hepatic Lipid Metabolism Through Modulating the Oxidative Stress in Male Adolescent Rats,” Environmental Analysis Health and Toxicology 39, no. 1 (2024): e2024007–0.
10.5620/eaht.2024007
PubMed Google Scholar
17Z. B. Zhao, K. Ji, X. Y. Shen, et al., “Di(2-ethylhexyl) Phthalate Promotes Hepatic Fibrosis by Regulation of Oxidative Stress and Inflammation Responses in Rats,” Environmental Toxicology and Pharmacology 68 (2019): 109–119.
10.1016/j.etap.2019.03.008
CAS PubMed Web of Science® Google Scholar
18P. H. Liao, H. H. Hsu, T. S. Chen, et al., “Phosphorylation of Cofilin-1 by ERK Confers HDAC Inhibitor Resistance in Hepatocellular Carcinoma Cells via Decreased ROS-Mediated Mitochondria Injury,” Oncogene 36, no. 14 (2017): 1978–1990.
10.1038/onc.2016.357
CAS PubMed Web of Science® Google Scholar
19R. Zhao, Q. Zhao, X. Wang, et al., “Yi-Qi-Jian-Pi Formula Inhibits Hepatocyte Pyroptosis Through the IDH2-Driven Tricarboxylic Acid Cycle to Reduce Liver Injury in Acute-on-Chronic Liver Failure,” Journal of Ethnopharmacology 317 (2023): 116683.
10.1016/j.jep.2023.116683
CAS PubMed Web of Science® Google Scholar
20G. Shen, L. Zhou, W. Liu, et al., “Di(2-ethylhexyl)phthalate Alters the Synthesis and Beta-Oxidation of Fatty Acids and Hinders ATP Supply in Mouse Testes via UPLC-Q-Exactive Orbitrap MS-Based Metabonomics Study,” Journal of Agricultural and Food Chemistry 65, no. 24 (2017): 5056–5063.
10.1021/acs.jafc.7b01015
CAS PubMed Web of Science® Google Scholar
21A. Loboda, M. Damulewicz, E. Pyza, et al., “Role of Nrf2/HO-1 System in Development, Oxidative Stress Response and Diseases: An Evolutionarily Conserved Mechanism,” Cellular and Molecular Life Sciences 73, no. 17 (2016): 3221–3247.
10.1007/s00018-016-2223-0
CAS PubMed Web of Science® Google Scholar
22E. H. Kobayashi, T. Suzuki, R. Funayama, et al., “Nrf2 Suppresses Macrophage Inflammatory Response by Blocking Proinflammatory Cytokine Transcription,” Nature Communications 7 (2016): 11624.
10.1038/ncomms11624
CAS PubMed Web of Science® Google Scholar
23L. He, C. Guo, C. Peng, and Y. Li, “Advances of Natural Activators for Nrf2 Signaling Pathway on Cholestatic Liver Injury Protection: A Review,” European Journal of Pharmacology 910 (2021): 174447.
10.1016/j.ejphar.2021.174447
CAS PubMed Web of Science® Google Scholar
24M. Sangineto, F. Grabherr, T. E. Adolph, et al., “Dimethyl fumarate Ameliorates Hepatic Inflammation in Alcohol Related Liver Disease,” Liver International 40, no. 7 (2020): 1610–1619.
10.1111/liv.14483
CAS PubMed Web of Science® Google Scholar
25A. R. Gafson, C. Savva, T. Thorne, et al., “Breaking the Cycle: Reversal of Flux in the Tricarboxylic Acid Cycle by Dimethyl Fumarate,” Neurology Neuroimmunology & Neuroinflammation 6, no. 3 (2019): e562.
10.1212/NXI.0000000000000562
PubMed Web of Science® Google Scholar
26D. Olagnier, E. Farahani, J. Thyrsted, et al., “SARS-CoV2-Mediated Suppression of NRF2-Signaling Reveals Potent Antiviral and Anti-Inflammatory Activity of 4-Octyl-Itaconate and Dimethyl Fumarate,” Nature Communications 11, no. 1 (2020): 4938.
10.1038/s41467-020-18764-3
CAS PubMed Web of Science® Google Scholar
27N. Yan, Z. Xu, C. Qu, and J. J. Zhang, “Dimethyl Fumarate Improves Cognitive Deficits in Chronic Cerebral Hypoperfusion Rats by Alleviating Inflammation, Oxidative Stress, and Ferroptosis via NRF2/ARE/NF-kappaB Signal Pathway,” International Immunopharmacology 98 (2021): 107844.
10.1016/j.intimp.2021.107844
CAS PubMed Web of Science® Google Scholar
28M. E. Mostafa, A. A. Shaaban, and H. A. Salem, “Dimethylfumarate Ameliorates Hepatic Injury and Fibrosis Induced by Carbon Tetrachloride,” Chemico-Biological Interactions 302 (2019): 53–60.
10.1016/j.cbi.2019.01.029
CAS PubMed Web of Science® Google Scholar
29P. Tveden-Nyborg, T. K. Bergmann, N. Jessen, U. Simonsen, and J. Lykkesfeldt, “BCPT 2023 Policy for Experimental and Clinical Studies,” Basic & Clinical Pharmacology & Toxicology 133, no. 4 (2023): 391–396.
10.1111/bcpt.13944
CAS PubMed Web of Science® Google Scholar
30M. R. Gallop, S. Y. Tobin, and A. Chaix, “Finding Balance: Understanding the Energetics of Time-Restricted Feeding in Mice,” Obesity (Silver Spring) 31, no. 1 (2023): 22–39.
10.1002/oby.23607
PubMed Google Scholar
31F. Zhao, L. Zhang, M. Qu, et al., “Obeticholic Acid Alleviates Intrauterine Growth Restriction Induced by Di-ethyl-hexyl Phthalate in Pregnant Female Mice by Improving Bile Acid Disorder,” Environmental Science and Pollution Research International 30, no. 51 (2023): 110956–110969.
10.1007/s11356-023-30149-9
CAS PubMed Web of Science® Google Scholar
32A. R. Vanani, H. Kalantari, M. Mahdavinia, M. Rashno, L. Khorsandi, and M. J. Khodayar, “Dimethyl Fumarate Reduces Oxidative Stress, Inflammation and Fat Deposition by Modulation of Nrf2, SREBP-1c and NF-kappaB Signaling in HFD Fed Mice,” Life Sciences 283 (2021): 119852.
10.1016/j.lfs.2021.119852
CAS PubMed Web of Science® Google Scholar
33Z. Xu, W. Tang, Q. Xie, et al., “Dimethyl Fumarate Attenuates Cholestatic Liver Injury by Activating the NRF2 and FXR Pathways and Suppressing NLRP3/GSDMD Signaling in Mice,” Experimental Cell Research 432, no. 2 (2023): 113781.
10.1016/j.yexcr.2023.113781
CAS PubMed Web of Science® Google Scholar
34J. Sampson and D. de Korte, “DEHP-Plasticised PVC: Relevance to Blood Services,” Transfusion Medicine 21, no. 2 (2011): 73–83.
10.1111/j.1365-3148.2010.01056.x
CAS PubMed Web of Science® Google Scholar
35H. Chen, W. Zhang, B. B. Rui, S. M. Yang, W. P. Xu, and W. Wei, “Di(2-ethylhexyl) Phthalate Exacerbates Non-Alcoholic Fatty Liver in Rats and Its Potential Mechanisms,” Environmental Toxicology and Pharmacology 42 (2016): 38–44.
10.1016/j.etap.2015.12.016
PubMed Web of Science® Google Scholar
36G. Li, C. Y. Zhao, Q. Wu, et al., “Integrated Metabolomics and Transcriptomics Reveal Di(2-ethylhexyl) Phthalate-Induced Mitochondrial Dysfunction and Glucose Metabolism Disorder Through Oxidative Stress in Rat Liver,” Ecotoxicology and Environmental Safety 228 (2021): 112988.
10.1016/j.ecoenv.2021.112988
CAS PubMed Web of Science® Google Scholar
37P. H. Pan, Y. Y. Wang, S. Y. Lin, et al., “Plumbagin Ameliorates Bile Duct Ligation-Induced Cholestatic Liver Injury in Rats,” Biomedicine & Pharmacotherapy 151 (2022): 113133.
10.1016/j.biopha.2022.113133
CAS PubMed Web of Science® Google Scholar
38T. Yang, T. Shu, G. Liu, et al., “Quantitative Profiling of 19 Bile Acids in Rat Plasma, Liver, Bile and Different Intestinal Section Contents to Investigate Bile Acid Homeostasis and the Application of Temporal Variation of Endogenous Bile Acids,” Journal of Steroid Biochemistry and Molecular Biology 172 (2017): 69–78.
10.1016/j.jsbmb.2017.05.015
CAS PubMed Web of Science® Google Scholar
39J. Y. L. Chiang and J. M. Ferrell, “Bile Acids as Metabolic Regulators and Nutrient Sensors,” Annual Review of Nutrition 39 (2019): 175–200.
10.1146/annurev-nutr-082018-124344
CAS PubMed Web of Science® Google Scholar
40M. Singh, A. Singh, S. Kundu, S. Bansal, and A. Bajaj, “Deciphering the Role of Charge, Hydration, and Hydrophobicity for Cytotoxic Activities and Membrane Interactions of Bile Acid Based Facial Amphiphiles,” Biochimica et Biophysica Acta 1828, no. 8 (2013): 1926–1937.
10.1016/j.bbamem.2013.04.003
CAS PubMed Web of Science® Google Scholar
41A. P. Rolo, P. J. Oliveira, A. J. Moreno, et al., “Bile Acids Affect Liver Mitochondrial Bioenergetics: Possible Relevance for Cholestasis Therapy,” Toxicological Sciences 57, no. 1 (2000): 177–185.
10.1093/toxsci/57.1.177
CAS PubMed Web of Science® Google Scholar
42S. Y. Cai and J. L. Boyer, “The Role of Inflammation in the Mechanisms of Bile Acid-Induced Liver Damage,” Digestive Diseases 35, no. 3 (2017): 232–234.
10.1159/000450916
PubMed Web of Science® Google Scholar
43E. Gonzalez-Sanchez, M. J. Perez, N. S. Nytofte, et al., “Protective Role of Biliverdin Against Bile Acid-Induced Oxidative Stress in Liver Cells,” Free Radical Biology & Medicine 97 (2016): 466–477.
10.1016/j.freeradbiomed.2016.06.016
CAS PubMed Web of Science® Google Scholar
44C. T. Shearn, A. L. Anderson, C. G. Miller, et al., “Thioredoxin Reductase 1 Regulates Hepatic Inflammation and Macrophage Activation During Acute Cholestatic Liver Injury,” Hepatology Communications 7, no. 1 (2023): e0020.
10.1097/HC9.0000000000000020
PubMed Web of Science® Google Scholar
45W. Q. Ren, N. Liu, Y. Shen, et al., “Subchronic Exposure to Di-(2-ethylhexyl) Phthalate (DEHP) Elicits Blood-Brain Barrier Dysfunction and Neuroinflammation in Male C57BL/6J Mice,” Toxicology 499 (2023): 153650.
10.1016/j.tox.2023.153650
CAS PubMed Web of Science® Google Scholar
46X. Zhen, L. Jindong, Z. Yang, et al., “Activation of Nrf2 Pathway by Dimethyl Fumarate Attenuates Renal Ischemia-Reperfusion Injury,” Transplantation Proceedings 53, no. 7 (2021): 2133–2139.
10.1016/j.transproceed.2021.07.017
CAS PubMed Google Scholar
47K. Zhao and L.-B. Wen, “DMF Attenuates Cisplatin-Induced Kidney Injury via Activating Nrf2 Signaling Pathway and Inhibiting NF-kB Signaling Pathway,” European Review for Medical and Pharmacological Sciences 22, no. 24 (2018): 8924–8931.
CAS PubMed Google Scholar
48F. He, X. Ru, and T. Wen, “NRF2, a Transcription Factor for Stress Response and Beyond,” International Journal of Molecular Sciences 21, no. 13 (2020): 21134777.
10.3390/ijms21134777
Web of Science® Google Scholar
49M. Q. Wang, K. H. Zhang, F. L. Liu, et al., “Wedelolactone Alleviates Cholestatic Liver Injury by Regulating FXR-Bile Acid-NF-kappaB/NRF2 Axis to Reduce Bile Acid Accumulation and Its Subsequent Inflammation and Oxidative Stress,” Phytomedicine 122 (2024): 155124.
10.1016/j.phymed.2023.155124
CAS PubMed Web of Science® Google Scholar
50Y. Zhao, Z. H. Du, M. Talukder, et al., “Crosstalk Between Unfolded Protein Response and Nrf2-Mediated Antioxidant Defense in Di-(2-ethylhexyl) Phthalate-Induced Renal Injury In Quail (Coturnix japonica),” Environmental Pollution 242, no. Pt B (2018): 1871–1879.
10.1016/j.envpol.2018.07.080
CAS PubMed Google Scholar
51T. Toyama, A. P. Looney, B. M. Baker, et al., “Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis,” Journal of Investigative Dermatology 138, no. 1 (2018): 78–88.
10.1016/j.jid.2017.08.024
CAS PubMed Web of Science® Google Scholar
52W. X. Zhang, J. H. Zhao, F. M. Ping, et al., “Effect of Dimethyl Fumarate on Rats With Chronic Pancreatitis,” Asian Pacific Journal of Tropical Medicine 9, no. 3 (2016): 261–264.
10.1016/j.apjtm.2016.01.023
CAS PubMed Web of Science® Google Scholar
53G. O. Gillard, B. Collette, J. Anderson, et al., “DMF, but Not Other Fumarates, Inhibits NF-kappaB Activity In Vitro in an Nrf2-Independent Manner,” Journal of Neuroimmunology 283 (2015): 74–85.
10.1016/j.jneuroim.2015.04.006
CAS PubMed Web of Science® Google Scholar
54U. Schulze-Topphoff, M. Varrin-Doyer, K. Pekarek, et al., “Dimethyl Fumarate Treatment Induces Adaptive and Innate Immune Modulation Independent of Nrf2,” Proceedings of the National Academy of Sciences of the United States of America 113, no. 17 (2016): 4777–4782.
10.1073/pnas.1603907113
CAS PubMed Web of Science® Google Scholar

Volume136, Issue6

June 2025

e70047

This article also appears in:

BCPT Young Investigator's Award Collection 2025

TCA Cycle Intermediate Mitigates Di(2-ethylhexyl) Phthalate-Induced Cholestatic Liver Injury Through Modulation of the Nrf2/NQO1 Signalling Axis

ABSTRACT

Conflicts of Interest

Open Research

Data Availability Statement

References

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

TCA Cycle Intermediate Mitigates Di(2-ethylhexyl) Phthalate-Induced Cholestatic Liver Injury Through Modulation of the Nrf2/NQO1 Signalling Axis

ABSTRACT

Conflicts of Interest

Open Research

Data Availability Statement

References

References

Related

Information